Prospective Assessment of Rejection in Kidney Transplant (PARK)

The PARK study is a multi-center observational study to assess the performance of the QSant test with kidney biopsy.QSant is a test based on 6 urinary biomarkers that is used for the evaluation and management of acute rejection in renal allograft recipients with clinical suspicion of rejection.

Inclusion Criteria:Kidney transplant recipient ≥ 18 years who are scheduled for kidney biopsy.Kidney biopsy scheduled on a date > 14 days post-transplantAble to understand risks and requirements of participation and provide informed consentWilling and able to comply with the study requirementsExclusion Criteria:Inability to provide a voided urine sample per collection protocolUrological abnormalities such as catheters, augmented bladder, ileal conduits, mitrofanoff, and vesicostomyHistory of or current multi-organ transplant